Trump plans to sign an order to cut US drug costs by up to 80% via international pricing.

Donald Trump plans to sign an executive order aimed at reducing prescription drug costs in the US by up to 80% through a "most favored nation" policy. The plan would align US drug prices with the lowest international rates, targeting Medicare. Critics argue this could harm drug innovation, and a similar initiative in Trump's first term was blocked by a court.